Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Psoriasis on the scalp causes smaller oil glands and thinner hair but doesn't lead to hair loss.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

TNF-alpha inhibitors can cause various immune-related skin issues.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

New and repurposed treatments are improving outcomes in dermatology.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Secukinumab for psoriasis may cause hair loss.

Psoriasis can cause temporary or permanent hair loss.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Psoriasis lesions have fewer and smaller oil glands, which might affect the condition's development.